
Weight gain is a common side effect of antipsychotic medications and is of particular concern with most of the newer zzso zzso It is, therefore, increasingly important to understand the impact of obesity and perceived weight problems on compliance with these zzso 

A survey of treatment and health issues was mailed to local chapters of the National Alliance for the zzso Ill zzso and National Mental Health Association zzso who distributed them to people with zzso zzso was defined as a self-report of missing any antipsychotic medication in the previous zzso The primary independent variables were zzso body mass index zzso weight zzso zzso as normal zzso zzso zzso zzso overweight zzso zzso zzso zzso or obese zzso 30, zzso zzso zzso zzso zzso distress over weight zzso Other independent variables included zzso medication attitudes, and treatment zzso 

zzso status and zzso distress from weight gain were zzso of zzso zzso individuals were more than twice as likely as those with a normal zzso to report missing their medication zzso zzso zzso zzso zzso A comprehensive model suggested that the primary zzso of noncompliance was distress over weight zzso 

There appears to be a zzso positive association between obesity and zzso distress from weight gain and medication zzso even when accounting for other possible zzso zzso 

